medline.ch Dermatologie Tumoren Anderes

	Metabolomic Insights into Head and Neck Cancer: Recent Advances and Future Directions. Curr Oncol Ponneganti S, Lavudi K, Thalla M, Narkhede G, Dwivedi R, Kokkanti R, Pandey P. PMID: 42041718 [PubMed - indexed for MEDLINE]
	Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study and Literature Review. Curr Oncol Raku, Bi, Vu, Kotromanovi, Eri, Viculin J, Vazdar L, Prpi, Kust D, Vu. PMID: 42041702 [PubMed - indexed for MEDLINE]
	Subtotal and total glossectomies with or without total laryngectomy - Does laryngeal preservation impact oncological and functional outcomes? Acta Otorhinolaryngol Ital Montenegro C, Mattavelli D, Tomasoni M, Nassih FE, Belponer G, Modesti C, Pinacoli A, Rampinelli V, Lancini D, Grammatica A, Piazza C. PMID: 42041066 [PubMed - indexed for MEDLINE]
	EGFR-targeted photoimmunotherapy and its association with the immune microenvironment in locoregional recurrent head and neck squamous cell carcinoma. Front Immunol Yoshizawa K, Tsujikawa T, Leelasawatsuk P, Bedeir MM, van der Aar Y, de Martines T, Shibata S, Ogi H, Okada R, Kimura A, Morimoto H, Saburi S, Mukudai S, Nagao H, Miyagawa-Hayashino A, Konishi E, Itoh K, Asakage T, Hirano S. PMID: 42039183 [PubMed - indexed for MEDLINE]
	Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma. Front Immunol He J, Pang K, Zhou Z, Yang C, Chen Y, He S, Wang F, Li P. PMID: 42039177 [PubMed - indexed for MEDLINE]
	Advances and challenges in immunotherapy for advanced esophageal squamous cell carcinoma. Front Immunol Wang Y, Li H, Zhao P, Li Z, Zhang S. PMID: 42039176 [PubMed - indexed for MEDLINE]
	PD-L1 expression patterns in stage IB1 cervical squamous cell carcinoma: a retrospective study on implications for tumor budding and immune microenvironment. PeerJ Lu S, Liu K, Luo W, Zheng S. PMID: 42038463 [PubMed - indexed for MEDLINE]
	The Role of Chemopreventive Agents in the Management of Oral Potentially Malignant Disorders and Oral Cancer: A Narrative Review. Cancer Rep (Hoboken) Sayal L, Hamadah O, Chatty E, Abdo A, Aghbari S, Munasser A, Alnour A. PMID: 42032821 [PubMed - indexed for MEDLINE]
	Multimodal Radiogenomic Imaging in Oropharyngeal Squamous Cell Carcinoma: Implications for Dentomaxillofacial Radiology. Med Sci (Basel) Barioni ED, Orhan K, Borges-Oliveira AC, Lopes SLPC, Costa ALF. PMID: 42029598 [PubMed - indexed for MEDLINE]
	Malignant Transformation of Craniopharyngioma: A rare case after 32 years of follow-up. Kathmandu Univ Med J (KUMJ) Orhan G, Bozer A. PMID: 42028781 [PubMed - indexed for MEDLINE]
	Inhibitory role of angiopoietinâ€‘like 4 for cancer progression in oropharyngeal squamous cell carcinoma. Oncol Rep Mikoshiba T, Sekimizu M, Nakahara N, Saito S, Yoshihama K, Nagai R, Kono T, Ozawa H. PMID: 42028751 [PubMed - indexed for MEDLINE]
	METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review). Int J Oncol Pu C, Hu H, Fan H, Chen T, Tang J. PMID: 42028733 [PubMed - indexed for MEDLINE]
	Biomarkers for oesophageal squamous cell carcinoma and the role of HPV: Multiâ€‘omics approaches and current evidence (Review). Int J Oncol Zou L, Zhao H, Zhang J, Xie J, An X, Qi X, Yue Y, Zhang L, Zhang X, Liu K. PMID: 42028731 [PubMed - indexed for MEDLINE]
	Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway. JCO Precis Oncol Saijo K, Imai H, Iwasaki T, Ishii R, Higashi K, Ohkoshi A, Yamazaki Y, Shirakawa T, Saito R, Wakayama S, Numakura R, Yoshida Y, Taniguchi S, Kasahara Y, Ouchi K, Komine K, Shirota H, Takahashi M, Suzuki T, Katori Y, Ishioka C, Kawakami H. PMID: 42024838 [PubMed - indexed for MEDLINE]
	Metabolic reprogramming in head and neck cancer: therapeutic opportunities and challenges. J Pharm Pharmacol Bani-Ahmad E, Dass J, Dass CR. PMID: 42023694 [PubMed - indexed for MEDLINE]
	Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma. J Immunother Cancer Zhang R, Qi S, Zhou Y, Hu Y, Li Y, Li Y, Qin J, Yang AR, Zhang H, Liu Z, Li Y. PMID: 42019971 [PubMed - indexed for MEDLINE]
	Preoperative computed tomography for assessment of bone invasion in oral squamous cell carcinoma: diagnostic accuracy and anatomical subsite dependency. J Cancer Res Clin Oncol Ketschau J, Leonhardt Y, Grabenhorst A, Singer H, Kram H, Krautkremer N, Leopold C, Mohr J, Stimmer H, Wolff KD, Ritschl LM. PMID: 42017973 [PubMed - indexed for MEDLINE]
	Histopathological spectrum of oral squamous cell carcinoma in Naswar users: Correlation with duration, age and site. J Pak Med Assoc Iqbal F, Bashir N, Maryam H, Ahmad S. PMID: 42017720 [PubMed - indexed for MEDLINE]
	Retrospective analysis of the optimal timing of immunotherapy in patients with advanced esophageal squamous cell carcinoma: a window of opportunity. Dis Esophagus Wang W, Ye L, Ruan K, Li H, Mao W, Ji Y, Xu X. PMID: 42017418 [PubMed - indexed for MEDLINE]
	Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review. Hum Vaccin Immunother Xu M, Qiu S, Zhou J, Zhang Y. PMID: 42012232 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 60108

Seite 1 von 3006

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung